Corcept Therapeutics Insider Trades

CORT

Track insider trading activity from Corcept Therapeutics executives and directors. See which insiders are buying and selling CORT stock.

Trades Last 12 Months

CORT Price

All Insider Trades for Corcept Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Wilson James N Director
Holding Value $119M 1,067,743 shares
Last Trade
Sep 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.11M 10,000 shares
$110.69
$111.81
Lyon Joseph Douglas See Remarks
Holding Value $466k 4,167 shares
Last Trade
Sep 14, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.12M 10,000 shares
$111.80
$111.81
Mokari Atabak Chief Financial Officer
Holding Value $1.82M 16,304 shares
Last Trade
Sep 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.6k 102 shares
$113.38
$111.81
Robb Gary Charles Chief Business Officer
Holding Value $1.53M 13,663 shares
Last Trade
Sep 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.3k 91 shares
$113.38
$111.81
Maduck Sean See Remarks
Holding Value $1.11M 9,938 shares
Last Trade
Sep 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.3k 117 shares
$113.38
$111.81
Vieira Roberto Wandenkolk President, Oncology
Holding Value $474k 4,242 shares
Last Trade
Sep 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.6k 102 shares
$113.38
$111.81
Guyer William Chief Development Officer
Holding Value $482k 4,313 shares
Last Trade
Sep 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.2k 328 shares
$113.38
$111.81
Park Kimberly Director
Holding Value $0 0 shares
Last Trade
Aug 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.27M 26,685 shares
$122.55
$111.81
Mahoney David L Director
Holding Value $138M 1,232,161 shares
Last Trade
Aug 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.3M 103,606 shares
$118.26
$111.81
Belanoff Joseph K Chief Executive Officer
Holding Value $287M 2,565,489 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$895k 12,837 shares
$69.74
$111.81
Murray Joshua M. Director
Holding Value $1.4M 12,500 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$746k 12,500 shares
$59.69
$111.81
Holding Value $1.4M 12,500 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$746k 12,500 shares
$59.69
$111.81
Alton Gregg H Director
Holding Value $1.4M 12,500 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$746k 12,500 shares
$59.69
$111.81
Mahoney David L Director
Holding Value $1.4M 12,500 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$746k 12,500 shares
$59.69
$111.81
Wilson James N Director
Holding Value $1.4M 12,500 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$746k 12,500 shares
$59.69
$111.81
Holding Value $1.4M 12,500 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$746k 12,500 shares
$59.69
$111.81
Belanoff Joseph K Chief Executive Officer
Holding Value $322M 2,878,326 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2M 40,000 shares
$50.10
$111.81
Hunt Hazel Chief Scientific Officer
Holding Value $15.7M 140,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 140,000 shares
$35.70
$111.81
Cannon Gillian Director
Holding Value $0 0 shares
Last Trade
Sep 10, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$529k 7,393 shares
$71.62
$111.81
Grauer Andreas Chief Medical Officer
Holding Value $22.4M 200,000 shares
Last Trade
Feb 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.88M 200,000 shares
$29.41
$111.81

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up